BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30038465)

  • 1. Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.
    Panisello-Roselló A; Lopez A; Folch-Puy E; Carbonell T; Rolo A; Palmeira C; Adam R; Net M; Roselló-Catafau J
    World J Gastroenterol; 2018 Jul; 24(27):2984-2994. PubMed ID: 30038465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress.
    Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ
    Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with the ALDH2 agonist Alda-1 reduces intestinal injury induced by ischaemia and reperfusion in mice.
    Zhu Q; He G; Wang J; Wang Y; Chen W
    Clin Sci (Lond); 2017 Jun; 131(11):1123-1136. PubMed ID: 28325855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice.
    Li M; Xu M; Li J; Chen L; Xu D; Tong Y; Zhang J; Wu H; Kong X; Xia Q
    J Immunol Res; 2018; 2018():9807139. PubMed ID: 30671488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alda-1 Attenuates Lung Ischemia-Reperfusion Injury by Reducing 4-Hydroxy-2-Nonenal in Alveolar Epithelial Cells.
    Ding J; Zhang Q; Luo Q; Ying Y; Liu Y; Li Y; Wei W; Yan F; Zhang H
    Crit Care Med; 2016 Jul; 44(7):e544-52. PubMed ID: 26757166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes.
    Fu SH; Zhang HF; Yang ZB; Li TB; Liu B; Lou Z; Ma QL; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):87-94. PubMed ID: 24081521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with the ALDH2 activator Alda‑1 protects rat livers from ischemia/reperfusion injury by inducing autophagy.
    Liu Z; Ye S; Zhong X; Wang W; Lai CH; Yang W; Yue P; Luo J; Huang X; Zhong Z; Xiong Y; Fan X; Li L; Wang Y; Ye Q
    Mol Med Rep; 2020 Sep; 22(3):2373-2385. PubMed ID: 32705206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1.
    Gomes KM; Bechara LR; Lima VM; Ribeiro MA; Campos JC; Dourado PM; Kowaltowski AJ; Mochly-Rosen D; Ferreira JC
    Int J Cardiol; 2015 Jan; 179():129-38. PubMed ID: 25464432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia Injury.
    Panisello-Roselló A; Alva N; Flores M; Lopez A; Castro Benítez C; Folch-Puy E; Rolo A; Palmeira C; Adam R; Carbonell T; Roselló-Catafau J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30131474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Activation Of Aldehyde Dehydrogenase 2 Protects Against Heatstroke-Induced Acute Lung Injury by Modulating Oxidative Stress and Endothelial Dysfunction.
    Tsai HY; Hsu YJ; Lu CY; Tsai MC; Hung WC; Chen PC; Wang JC; Hsu LA; Yeh YH; Chu P; Tsai SH
    Front Immunol; 2021; 12():740562. PubMed ID: 34764958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy.
    Guo Y; Yu W; Sun D; Wang J; Li C; Zhang R; Babcock SA; Li Y; Liu M; Ma M; Shen M; Zeng C; Li N; He W; Zou Q; Zhang Y; Wang H
    Biochim Biophys Acta; 2015 Feb; 1852(2):319-31. PubMed ID: 24874076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1.
    Chen L; Lang AL; Poff GD; Ding WX; Beier JI
    Redox Biol; 2019 Jun; 24():101205. PubMed ID: 31026768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
    Yang MY; Wang YB; Han B; Yang B; Qiang YW; Zhang Y; Wang Z; Huang X; Liu J; Chen YD; Ren J; Cao F; Xu Y
    Acta Pharmacol Sin; 2018 Jan; 39(1):48-58. PubMed ID: 28858301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice.
    Zhong W; Zhang W; Li Q; Xie G; Sun Q; Sun X; Tan X; Sun X; Jia W; Zhou Z
    J Hepatol; 2015 Jun; 62(6):1375-81. PubMed ID: 25543082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury.
    Luo XJ; Liu B; Ma QL; Peng J
    Curr Drug Targets; 2014; 15(10):948-55. PubMed ID: 25163552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
    Stachowicz A; Olszanecki R; Suski M; Wiśniewska A; Totoń-Żurańska J; Madej J; Jawień J; Białas M; Okoń K; Gajda M; Głombik K; Basta-Kaim A; Korbut R
    J Am Heart Assoc; 2014 Nov; 3(6):e001329. PubMed ID: 25392542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehyde dehydrogenase 2 regulates autophagy via the Akt-mTOR pathway to mitigate renal ischemia-reperfusion injury in hypothermic machine perfusion.
    Lin D; Xiang T; Qiu Q; Leung J; Xu J; Zhou W; Hu Q; Lan J; Liu Z; Zhong Z; Wang Y; Ye Q
    Life Sci; 2020 Jul; 253():117705. PubMed ID: 32334008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alda-1 modulates the kinetic properties of mitochondrial aldehyde dehydrogenase (ALDH2).
    Belmont-Díaz JA; Yoval-Sánchez B; Calleja-Castañeda LF; Pardo Vázquez JP; Rodríguez-Zavala JS
    FEBS J; 2016 Oct; 283(19):3637-3650. PubMed ID: 27521998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alda-1, an aldehyde dehydrogenase-2 agonist, causes deterioration in renal functions following ischemia-reperfusion injury due to crystalline nephropathy.
    Hammad FT; Al-Salam S; Yuvaraju P; Lubbad L
    Drug Dev Res; 2018 Nov; 79(7):315-323. PubMed ID: 30291750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Aldehyde Dehydrogenase 2 Mutant (ALDH2*2) Mice Are More Susceptible to Cardiac Ischemic-Reperfusion Injury Due to 4-Hydroxy-2-Nonenal Induced Coronary Endothelial Cell Damage.
    Pan G; Roy B; Palaniyandi SS
    J Am Heart Assoc; 2021 Sep; 10(18):e021140. PubMed ID: 34482710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.